Boone Hospital Center, Columbia, MO, USA.
Department of Otolaryngology, Head and Neck Surgery, University of Arkansas for Medical Sciences, Little Rock, AR, USA.
Curr Allergy Asthma Rep. 2018 May 29;18(7):37. doi: 10.1007/s11882-018-0792-8.
Pediatric chronic rhinosinusitis (CRS) is a common disorder that carries significant morbidity. The diagnosis requires sinus symptoms that persist despite standard medical therapy greater than 3 months. Viral infections, allergies, and anatomic differences in children lead to chronic obstruction of the osteomeatal complex.
Chronic rhinosinusitis as a diagnosis is a conglomeration of multiple phenotypes and endotypes. As such, the diagnosis and management are complex. New survey studies provide some consensus on prevalence and management of this disease in children. In this review, we highlight the differential diagnosis of pediatric CRS, including non-eosinophilic/infectious variants, eosinophilic variants with and without nasal polyps, allergic fungal sinusitis, aspirin-exacerbated respiratory disease, primary immunodeficiency, and disorders of mucociliary clearance. Further, we detail treatment options that should be considered. Finally, we feature emerging potential treatment options of CRS, including anti-immunoglobulin E, interleukin-5, and interleukin-4 receptor alpha subunit.
小儿慢性鼻-鼻窦炎(CRS)是一种常见疾病,具有显著的发病率。其诊断需要在标准药物治疗 3 个月以上后仍持续存在鼻窦症状。儿童的病毒感染、过敏和解剖差异导致中鼻道复合体的慢性阻塞。
作为一种诊断,慢性鼻-鼻窦炎是多种表型和内型的组合。因此,其诊断和管理非常复杂。新的调查研究就该疾病在儿童中的患病率和管理提供了一些共识。在这篇综述中,我们重点介绍了小儿 CRS 的鉴别诊断,包括非嗜酸性/感染性变异、伴或不伴鼻息肉的嗜酸性变异、变应性真菌性鼻窦炎、阿司匹林加重的呼吸道疾病、原发性免疫缺陷和黏液纤毛清除功能障碍。此外,我们详细介绍了应考虑的治疗选择。最后,我们介绍了 CRS 的一些新的潜在治疗方法,包括抗免疫球蛋白 E、白细胞介素-5 和白细胞介素-4 受体α亚基。